#211 Breaking Down MASLD vs. MASH and the MAESTRO-NASH & ESSENCE Trials: Beyond Journal Club Segment

Core IM | Internal Medicine Podcast by Core IM Team

Jun 29, 202633:40Science & Medicine

MASLD affects nearly one in three adults worldwide, yet many patients remain undiagnosed until advanced fibrosis or cirrhosis develops. So, which patients should clinicians actually be screening? When is a FIB-4 enough,...

Related Episodes

Continue listening to more episodes from Core IM | Internal Medicine Podcast.

#216 Clinician Grief: At the Beside Segment

Sep 8, 2026 - 39:59

Have you ever lost a patient and found yourself thinking about them long after the shift ended? This epis...

#215 Gallbladder & Biliary Testing: 5 Pearls Segment

Aug 25, 2026 - 34:34

How to choose between RUQ ultrasound, CT, HIDA, MRCP, EUS, and ERCP based on the clinical picture? When s...

#214 Hyponatremia Management: A Core IM Classic

Aug 12, 2026 - 44:57

Throwback: Should you really fluid-restrict every patient with SIADH? When can IV fluids make hyponatremi...

#213 Hypertension First-Line Medications Troubleshooting Bread & Butter Series

Jul 28, 2026 - 32:59

Why can lower-dose combinations be more effective and better tolerated than maximizing one medication? Ho...

#212 Top 10 Highlights of the New Lipid Guidelines

Jul 15, 2026 - 23:52

Learn from primary care docs what has been practiced and changed from the 2026 ACC/AHA Lipid Guidelines!...

#210 HTN in Dialysis: 5 Pearls Segment

Jun 17, 2026 - 25:39

What blood pressure should we target in patients on hemodialysis? Why volume control remains the foundati...

#209 Dialysis and Fluid Management: 5 Pearls Segment

Jun 10, 2026 - 31:54

Why is fluid management the most important part of dialysis care? This episode explores the fundamentals...

#208 AI vs. Human with Post-Op AFib: Bread & Butter Series

May 27, 2026 - 29:19

Can AI manage post-op atrial fibrillation or does medicine still require human judgment? Using post-op AF...